AstraZeneca reports total voting rights at 1.55 billion shares
NeutralFinancial Markets

AstraZeneca has announced that it currently has a total of 1.55 billion voting rights associated with its shares. This figure is significant as it reflects the company's governance structure and shareholder engagement. Understanding the voting rights can provide insights into the company's decision-making processes and how shareholders can influence corporate actions.
— Curated by the World Pulse Now AI Editorial System






